[1]
A. Kasurinen, A. Laitinen, A. Kokkola, U.-H. Stenman, C. Böckelman, and C. Haglund, “Tumor-associated trypsin inhibitor (TATI) and tumor-associated trypsin-2 (TAT-2) predict outcomes in gastric cancer”, AO, vol. 59, no. 6, pp. 681–688, Jun. 2020.